Expression of Interest - A Brief overview

Interested in investing in the cannabis industry? We are expanding. If you'd like to invest in Medicinal Cannabis in Australia, New Zealand and Europe you can express your interest on this link - submit an expression of interest. Below is an brief overview of our company and its objectives.

As a fully licensed Australian company, MOCA is gearing up its diversity in the international landscape and seeking investment in medical cannabis.


MOCA - Healing the World One Patient at a Time

We are a dedicated team of professionals, highly motivated by the enormous potential of medical cannabis. Our company is the fastest growing cannabis business in Australia & has recently received its federal licences to import & export medical marijuana.

Our unique range of high quality organic cannabis products is ready to import under the MOCA brand. MOCA’s medication reduces the cost by up to 25% of patient prescriptions for pain management, anxiety, epilepsy, multiple sclerosis, & palliative care.

Our state of the art facility in NSW is ready to dispatch to health care professionals. We are expanding our operations into New Zealand. Join us in our growth phase as a Co-Owner and be part of one of the world’s fastest growing industries.

Organic Products

We have sourced all our products from our partner cultivators and manufacturers around the world.

Medical Focus

We work with medical practitioners to provide a premium quality product for all approved patients.

Holistic Approach

Our approach is to provide high quality organic products to patients at reduced prices, based on our buying power.

Product / Service Details

Premium Organic Medical Cannabis Products - We supply a range of Cannabidiol (CBD) & THC/CBD, organic cannabis products which includes easy to take capsules, CBD oils, tinctures, sub-lingual & concentrates. All material is sourced directly from organic cultivators & produced using Good Manufacturing Practices. Our products are very competitively priced in the Australian market and we will expand the range in 2019/2020. We will commence cultivating cannabis plants in late 2019/early 2020 to produce our own MOCA branded products to treat many conditions including chronic pain, Crohn's disease, Epilepsy, Glaucoma and Multiple sclerosis. submit an expression of interest

Business Model

We have 2 revenue streams, which include the wholesale of cannabis medication to the healthcare industry in Australia and NZ targeting medical clinics & secondly, revenue from cultivation, production and sale of raw & refined cannabis to emerging markets.

Our goal is to become the largest medical cannabis supplier in Australasia. Commencing with importing CBD and THC products under the MOCA label into our state of the art federally licenced medical facility in NSW. We are working with the New Zealand government to establish a wholesale supply base which will expand into a cultivation facility. We anticipate licence approval in 2nd quarter 2019. We will grow the brand by controlling our supply chain. Proposed cultivation facility is designed to produce 2100 kg of organic medical cannabis per year, with a current retail value of $16.8 million. submit an expression of interest

Growing adoption of marijuana in several medical applications such as cancer, mental disorders, chronic pain & others is expected to propel revenue growth in near future.

Safer forms of ingesting marijuana such as tinctures, oils, vapes & other edibles are expected to positively reinforce market growth.

The number of conditions treated using medical marijuana is growing rapidly.

Mission & Objectives


To become a global leader in the development & commercialization of organic cannabis therapeutic products for a variety of clinical indications by growing unique strains of organic cannabis to supply established, existing and newly regulated markets

Business Objectives

We have partnered with a leading tech company to licence 100 websites including, we are focused on becoming a leading international producer, & wholesaler of cannabis based products. Objectives include:

1. Grow our wholesale MOCA product range.

2. Grow our client base in Australia & New Zealand.

3. Establish a licensed wholesale facility in New Zealand to cater to the emerging market.

4. Establish a cultivation facility in New Zealand.

5. Expand our cultivation bases exponentially to cater to international demand enabling us to grow our distribution network.


The local market is currently valued at $17.7 mil p/a and is expected to grow to $3 billion by 2028.

Australia and New Zealand are emerging markets & MOCA is a first mover with excellent distribution channels perfectly positioning us for international growth.

Legal global marijuana market is currently estimated at US$10 billion and is expected to reach US$146.4 billion by end of 2025, and US$500 billion when fully mature, according to a report by Grand View Research, Inc. submit an expression of interest